318 related articles for article (PubMed ID: 33395141)
21. Prognostic Significance of Enlarged Lymph Nodes in Stage II Colorectal Cancer.
Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Yamauchi S; Sugihara K; Ishihara S
Dis Colon Rectum; 2023 Nov; 66(11):e1097-e1106. PubMed ID: 37603828
[TBL] [Abstract][Full Text] [Related]
22. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
[TBL] [Abstract][Full Text] [Related]
23. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
[TBL] [Abstract][Full Text] [Related]
24. A Clinicopathological Feature-Based Nomogram for Predicting the Likelihood of D3 Lymph Node Metastasis in Right-Sided Colon Cancer Patients.
Long C; Feng M; Wang S; Ji H; Li Z; Zheng J; Jiang W; Yan J
Dis Colon Rectum; 2023 Jan; 66(1):75-86. PubMed ID: 34897214
[TBL] [Abstract][Full Text] [Related]
25. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
26. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
27. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
[TBL] [Abstract][Full Text] [Related]
28. CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer.
Olsson LM; Lindmark GE; Israelsson ACE; Korkocic D; Hammarström SG; Hammarström MKC
Dis Colon Rectum; 2021 Nov; 64(11):1354-1363. PubMed ID: 34192710
[TBL] [Abstract][Full Text] [Related]
29. The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
Chang CY; Lin CC; Lin HH; Lan YT; Chang SC; Wang HS; Yang SH; Chen WS; Lin JK; Jiang JK
Dis Colon Rectum; 2023 Oct; 66(10):e1032-e1042. PubMed ID: 36538674
[TBL] [Abstract][Full Text] [Related]
30. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
[TBL] [Abstract][Full Text] [Related]
33. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
[TBL] [Abstract][Full Text] [Related]
34. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
35. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
[TBL] [Abstract][Full Text] [Related]
36. Local Excision Versus Radical Resection for Grade 2 Rectal Neuroendocrine Tumors: A Multicenter Propensity Score-Matched Analysis.
Zeng X; Zhang R; Jiang W; Li C; Yu M; Liu W; Di M; Wu H; Sun Y; Xiong Z; Jiang C; Yu B; Zhou S; Li Y; Liao X; Xia L; Zhang W; Lin G; Tao K
Dis Colon Rectum; 2024 Jul; 67(7):911-919. PubMed ID: 38452369
[TBL] [Abstract][Full Text] [Related]
37. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
[TBL] [Abstract][Full Text] [Related]
38. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
[TBL] [Abstract][Full Text] [Related]
40. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
